The role of molecular genetics in the clinical management of sporadic medullary thyroid carcinoma: A systematic review.

There is a growing body of evidence that tumour genetic and epigenetic profiles can be used to risk stratify patients with sMTC. Further research should focus on the clinical applicability of these findings by investigating the possibility of tailoring management to an individual's tumour mutation profile.